Calyxt, a plant-based synthetic biology company, completed the merger with Cibus, an agricultural technology company that develops, and licenses gene edited plant traits to seed companies. Financial terms were not disclosed. "We are excited to combine our joint wealth of experience that consolidates landmark intellectual property in agricultural gene editing including Transcription Activator-like Effector Nucleases and Oligonucleotide Directed Mutagenesis. The merger of two of the original pioneers in what has become the field of gene editing in agriculture, will enable new and expanded partnerships and opportunities to make farming more productive and to create a new generation of sustainable ingredients that are renewable and low-carbon," Greg Gocal, Cibus Co-Founder, Executive Vice President and Chief Scientific Officer.